MedPath

Study on the effect of Naldemedine Tosilate by diet

Not Applicable
Conditions
opioid-induced constipation
Registration Number
JPRN-UMIN000029459
Lead Sponsor
ational Hospital Organization Takasaki General Medical Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
14
Inclusion Criteria

Not provided

Exclusion Criteria

1.Performance status(3-4) 2.artificial anus 3.ileus of intestine 4.patients taking specific dietary form (for example,liquid diet,etc) 5.Having regular use of Itraconazole,Fluconazole, Rifampicin,Ciclosporin 6.Patients who do not obtain written consent 7.Patients judged inappropriate by the research director

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Comparison of the change amount from the baseline of the number of SBM per week due to the difference in usage and the time from oral administration to the first SBM
Secondary Outcome Measures
NameTimeMethod
1) Change amount of NRS score 2) Change in rescue usage 3) Survey of senses by questionnaire
© Copyright 2025. All Rights Reserved by MedPath